Announcement Issued by Bumrungrad International Hospital
Bumrungrad's Unwavering Strength: 45 Years of Global Dominance, Middle East Revenue Skyrockets 45%
Hey there! Let's clear the air about the recent buzz surrounding Bumrungrad International Hospital. The article "Bumrungrad in Trouble! Oil Tycoons Disappear" (June 10, 2025) casts a shadow over our institution's reputation, but it's important to present accurate information. We're all about keeping our patients and the public well-informed.
For 45 years, Bumrungrad has been a beacon for medical excellence, attracting over a million patients from 190 countries annually. This unwavering trust we've built over the years has earned us global recognition, including being Thailand's only hospital to rank among the world's best by Newsweek for five consecutive years. We've also gathered numerous international accreditations and accolades.
Steady Growth and Vibrant Patient Pool
The claim that Middle Eastern patient revenue is plummeting is woefully misleading. Instead, our 2024 net revenue from Middle Eastern patients surged 45% compared to pre-pandemic levels! That's not all – revenue from Qatar exploded a whopping 558% during the same timeframe, demonstrating the enduring bond of trust with the region.
Contrary to the article's allegations, Bumrungrad didn't lose over 1.3 billion THB in income over the past nine months of 2024. The loss of Middle Eastern revenue, including Kuwait, amounted to a mere 551 million THB. This downturn was primarily due to domestic policy reforms in Kuwait, not service quality or patient preferences. Also, this dip was fully offset by growth from other Middle Eastern and international markets, as witnessed in our year-on-year EPS.
It's essential to clarify that 30% of Kuwaiti patients returned to Bumrungrad in 2024, bringing in 416 million THB in revenue. Patients from Qatar and the UAE also continued flocking to us, particularly for complex and specialized care.
Revenue Richness and International Flair
While the article neglects the diversity of Bumrungrad's patient base, it's important to emphasize that we cater to patients from over 190 nationalities. We've witnessed robust demand from Thai and expat patients, as well as from neighboring countries and other international markets. Revenue from Thai patients grew by 46% and expat revenue by 56% in 2024, noteworthy increases in high-acuity specialties, wellness, and preventive care.
As for discussing Q2 2025 revenue figures, let's refrain for now. Premature release can mislead investors and potentially violate compliance rules. That being said, we're staying focused on delivering top-notch care and ensuring the best possible outcomes for our patients. This commitment drives our consistent growth across vital markets, regardless of geography.
Our achievements are a testament to the deep dedication and expertise of our medical professionals, who are continually setting new standards in diagnostics and treatment. Patients consistently choose Bumrungrad for its specialized care because of our well-trained staff and the excellence exhibited by our clinical and non-clinical employees in providing care with compassion and integrity.
Pricing and Value Paradox
The article's comparison of basic health check-up packages is flat-out wrong. The entry-level package starts at 7,000 THB, NOT 16,100 THB as stated. The disparity in numbers raises questions about the accuracy of the article's analysis, especially considering that hospital check-up packages differ significantly in scope, design, and expertise.
Indeed, it's impossible to make straightforward price comparisons among hospitals. Each institution tailors its packages to its distinctive clinical capabilities, technologies, and patient focus. Even packages with similar names – like "basic," "regular," or "comprehensive" – vary immensely regarding diagnostic scope, tools utilized, and medical expertise. For instance, Bumrungrad includes advanced modalities like AI-powered photon-counting CT – a cutting-edge technology that delivers superior resolution with lower radiation exposure – in certain packages. This empowers earlier and more precise detection of potential health issues, further bolstering our commitment to precision and proactive care.
Ultimately, the value we provide goes far beyond the prices of our basic check-up packages. Our focus on delivering exceptional medical expertise, a strong track record in complex and critical care, proven outcomes, and highly personalized services create a higher perceived value for many patients. While affordability is crucial to some, others – including the majority of our Middle Eastern patients – choose Bumrungrad for the value, excellence, and unwavering commitment to care it offers.
Unyielding Resilience and Future Expansion
Bumrungrad has not only survived but thrived through four decades of global and domestic upheavals. Our resilience stems from staying nimble, adaptable, and dedicated to our patients' needs. We rigorously monitor market shifts, geopolitical developments, and emerging trends, like the breakneck pace of medical intelligence and AI advances, to ensure we stay ahead.
As an example, our proactive engagement with the Thai-Saudi CCHI framework underscores our ability to capitalize on lucrative opportunities. We've been invited to present at a wellness seminar in Riyadh and are now in advanced discussions to serve insured Saudi patients, initiatives expected to significantly boost our long-term strategic growth while broadening our revenue base.
In conclusion, while we appreciate the curiosity and constructive discourse encouraged by the media, the article's claims regarding Middle Eastern patients, financial assumptions, and price comparisons don't paint an accurate picture of the complexities of the healthcare business landscape nor the bigger context in which we operate. There's no factual basis linking our stock performance to the assumptions presented in the article, which ignores Bumrungrad's solid fundamentals, global reputation, and proactive strategies for long-term resilience.
Sincerely,
Ms.Napas PaorohityaChief Marketing OfficerBumrungrad International Hospital
- TAGS
- Bumrungrad International Hospital
- hospital
- healthcare
- statement
- misrepresentation
- resilience
- growth
- ** Middle East**
- ** diversified patient base**
- market shifts
- geopolitical developments
- emerging trends
- value proposition
- patients' needs
- proactive engagement
- Thai-Saudi CCHI framework
- insurance
- Saudi patients
- strategic growth
- revenue base
- In light of recent speculations regarding Bumrungrad International Hospital's financial stability, it's crucial to note that the Middle Eastern patient revenue didn't decline but rather surged by 45% in 2024 compared to pre-pandemic levels.
- The hospital's dedication to catering to a diverse patient base is evident, as evidenced by the robust demand from over 190 nationalities, including Thai and expat patients, neighboring countries, and other international markets.
- Bumrungrad's commitment to providing top-notch care is unwavering, as demonstrated by its high-acuity specialties, wellness, and preventive care services, which recorded 46% growth in revenue from Thai patients and 56% growth in revenue from expat patients in 2024.
